Pignolet Béatrice Sl, Gebauer Christina Mt, Liblau Roland S
INSERM-UMR1043; Toulouse, France ; CNRS, U5282; Toulouse, France ; Universite de Toulouse; UPS; Centre de Physiopathologie Toulouse Purpan (CPTP); Toulouse, France ; CHU Toulouse Purpan; Toulouse, France.
INSERM-UMR1043; Toulouse, France ; CNRS, U5282; Toulouse, France ; Universite de Toulouse; UPS; Centre de Physiopathologie Toulouse Purpan (CPTP); Toulouse, France.
Oncoimmunology. 2013 Dec 1;2(12):e27384. doi: 10.4161/onci.27384. Epub 2013 Dec 10.
Paraneoplastic neurological disorders (PNDs) are syndromes that develop in cancer patients when an efficient antitumor immune response, directed against antigens expressed by both malignant cells and healthy neurons, damages the nervous system. Herein, we analyze existing data on the mechanisms of loss of self tolerance and nervous tissue damage that underpin one of the most frequent PNDs, the anti-Hu syndrome. In addition, we discuss future directions and propose potential strategies aimed at blocking deleterious encephalitogenic immune responses while preserving the antineoplastic potential of treatment.
副肿瘤性神经系统疾病(PNDs)是癌症患者出现的综合征,当针对恶性细胞和健康神经元所表达抗原的有效抗肿瘤免疫反应损害神经系统时就会发生。在此,我们分析了关于自身耐受性丧失和神经组织损伤机制的现有数据,这些机制是最常见的PNDs之一——抗Hu综合征的基础。此外,我们讨论了未来的方向,并提出了潜在的策略,旨在阻断有害的致脑炎性免疫反应,同时保留治疗的抗肿瘤潜力。